Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012
Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019
Etiologic factors in patients with systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006
Clinical and laboratory features of systemic sclerosis with pulmonary involvement Source: Eur Respir J 2001; 18: Suppl. 33, 512s Year: 2001
Metabolic profiling of pulmonary vascular phenotypes in systemic sclerosis Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus Source: Eur Respir Rev 2011; 20: 277-286 Year: 2011
Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002
Experimental modeling of lung involvement due to systemic sclerosis. Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020
Pulmonary hypertension in systemic sclerosis: different phenotypes Source: Eur Respir Rev, 26 (145) 170056; 10.1183/16000617.0056-2017 Year: 2017
Anti-a-enolase antibodies in systemic sclerosis identify a subset of patients with diffuse cutaneous sclerosis and interstitial lung disease Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
The adoption of nintedanib in systemic sclerosis: the SENSCIS study Source: Breathe, 16 (2) 200005; 10.1183/20734735.0005-2020 Year: 2020
CCL18 as marker of disease progression in systemic sclerosis Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012
Longitudinal functional evaluation of interstitial lung disease in systemic sclerosis Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Induced sputum in systemic sclerosis: A new potential for biomarkers in SSc Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
The natural course of systemic sclerosis patients with interstitial lung involvement Source: Eur Respir J 2005; 26: Suppl. 49, 336s Year: 2005
Exercise limitation in systemic sclerosis Source: Eur Respir J 2005; 26: Suppl. 49, 107s Year: 2005
Significance of pulmonary involvement in systemic sclerosis (SSc)– data from the German SSc-network Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018
Interstitial lung disease in systemic sclerosis: where do we stand? Source: Eur Respir Rev 2015; 24: 411-419 Year: 2015
Pulmonary manifestations of systemic sclerosis, a report from Iran Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011